The role of zoledronic acid in the management of osteoporosis

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.29, Iss.10, 2010-10, pp. : 1079-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab

By Capozzi Anna Lello Stefano Pontecorvi Alfredo

Gynecological Endocrinology, Vol. 30, Iss. 6, 2014-06 ,pp. : 403-408

Informa Healthcare

Access to resources Recommend Favorite

Role of genetics in osteoporosis

By Recker Robert Deng Hong-Wen

Endocrine Journal, Vol. 17, Iss. 1, 2002-02 ,pp. : 55-66

Humana Press, Inc

Access to resources Recommend Favorite

Zoledronic acid: future potential use in rheumatology

By Maricic Michael

Future Rheumatology, Vol. 1, Iss. 5, 2006-10 ,pp. : 541-548

Future Medicine

Access to resources Recommend Favorite

Role of Hormonal Changes in the Pathogenesis of Osteoporosis in Men

By Khosla S.

Calcified Tissue International, Vol. 75, Iss. 2, 2004-08 ,pp. : 110-113

Springer Publishing Company

Access to resources Recommend Favorite

A more active role for gynecologists in the prevention of postmenopausal osteoporosis

By Ylikorkala Olavi

Gynecological Endocrinology, Vol. 24, Iss. 6, 2008-01 ,pp. : 293-294

Informa Healthcare

Access to resources Recommend Favorite